Cent Eur J Public Health 2022, 30(Supplement):S57-S62 | DOI: 10.21101/cejph.a7241

Occurrence of bacteria belonging to the genus Enterococcus and Staphylococcus on inanimate surfaces of selected hospital facilities and their nosocomial significance

Ondrej Zahornacký1, Štefan Porubčin1, Alena Rovňáková1, Pavol Jarčuška1, Štefánia Andraščíková3, Kvetoslava Rimárová2
1 Department of Infectiology and Travel Medicine, Faculty of Medicine, Pavol Jozef Šafárik University and Louis Pasteur University Hospital in Košice, Košice, Slovak Republic
2 Department of Public Health and Hygiene, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Košice, Slovak Republic
3 Department of Midwifery, Faculty of Health Care, University of Prešov, Prešov, Slovak Republic

Objectives: This work aimed to determine the representation and resistance of bacteria belonging to the genus Staphylococcus and Enterococcus on inanimate surfaces of two selected workplaces of the University Hospital of L. Pasteur in Košice (UHLP) and to investigate their importance in the hospital environment. The men's ward of the Department of Internal Medicine (DIM) and the Department of Anaesthesiology and Intensive Care (DAIC) were chosen.

Methods: Using sterile sampling kits, a total of 182 swabs were collected from the inanimate surfaces of both UHLP workplaces. The swabs were then transported to a microbiological laboratory and inoculated onto sterile culture media (blood agar containing 5% ram erythrocytes). After culturing (24-48 hours, in a thermostat at constant temperature 37 °C), bacterial colonies were identified by mass spectrometry on a MALDI TOF MS. Bacteria belonging to the genera Staphylococcus and Enterococcus were subsequently separated from the spectrum of identified bacteria. Nosocomial significant strains of staphylococci (Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus aureus) and all isolated enterococci were subjected to susceptibility testing for selected antibiotics using the disk diffusion method - E-tests.

Results: Several members of the genus Staphylococcus were identified from the inanimate surfaces of both workplaces. These were mainly coagulase-negative strains - Staphylococcus epidermidis (45), Staphylococcus capitis (34), Staphylococcus haemolyticus (20), Staphylococcus hominis (45), Staphylococcus pasteuri (2), Staphylococcus sroph (1), Staphylococcus simulans (3), and Staphylococcus warneri (4). Staphylococcus aureus strains were also identified (2). Nosocomial significant isolates were tested for susceptibility to the antibiotics cefoxitin (FOX) and oxacillin (OXA). Two members of the genus Enterococcus - Enterococcus faecium (7) and Enterococcus faecalis (8) were isolated. All strains were subject to vancomycin susceptibility testing using the disk method.

Conclusion:

Keywords: nosocomial, inanimate surfaces, Enterococcus, Staphylococcus

Received: December 12, 2021; Revised: February 4, 2022; Accepted: February 4, 2022; Published: June 27, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zahornacký O, Porubčin Š, Rovňáková A, Jarčuška P, Andraščíková Š, Rimárová K. Occurrence of bacteria belonging to the genus Enterococcus and Staphylococcus on inanimate surfaces of selected hospital facilities and their nosocomial significance. Cent Eur J Public Health. 2022;30(Supplement):S57-62. doi: 10.21101/cejph.a7241. PubMed PMID: 35841227.
Download citation

References

  1. European Centre for Disease Prevention and Control. Healthcare-associated infections acquired in intensive care units. Annual epidemiological report for 2017 [Internet]. Stockholm: ECDC; 2019 [cited 2022 Feb 2]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-HAI.pdf.
  2. Chabi R, Momtaz H. Virulence factors and antibiotic resistance properties of the staphylococcus epidermidis strains isolated from hospital infections in Ahvaz, Iran. Trop Med Health. 2019 Dec 5;47:56. doi: 10.1186/s41182-019-0180-7. Go to original source... Go to PubMed...
  3. Nguyen TH, Park MD, Otto M. Host response to staphylococcus epidermidis colonization and infections. Front Cell Infect Microbiol. 2017 Mar 21;7:90. doi: 10.3389/fcimb.2017.00090. Go to original source... Go to PubMed...
  4. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000 Oct;13(4):686-707. Go to original source... Go to PubMed...
  5. Akbari R, Fattahi Bafghi M, Fazeli H. Nosocomial infections pathogens isolated from hospital personnel, hospital environment and devices. J Med Bacteriol. 2018;7(1/2):22-30.
  6. La Fauci V, Riso R, Facciolà A, Merlina V, Squeri R. Surveillance of microbiological contamination and correct use of protective lead garments. Ann Ig. 2016 Sep-Oct;28(5):360-6. Go to PubMed...
  7. Wang L, Zhou KH, Chen W, Yu Y, Feng SF. Epidemiology and risk factors for nosocomial infection in the respiratory intensive care unit of a teaching hospital in China: A prospective surveillance during 2013 and 2015. BMC Infect Dis. 2019 Feb 12;19(1):145. doi: 10.1186/s12879-019-3772-2. Go to original source... Go to PubMed...
  8. Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol. 2010 May;48(5):1549-54. Go to original source... Go to PubMed...
  9. Różańska A, Romaniszyn D, Chmielarczyk A, Bulanda M. Bacteria contamination of touch surfaces in Polish hospital wards. Med Pr. 2017 Jun 27;68(4):459-67. Go to original source... Go to PubMed...
  10. Dortet L, Glaser P, Kassis-Chikhani N, Girlich D, Ichai P, Boudon M, et al. Long-lasting successful dissemination of resistance to oxazolidinones in MDR staphylococcus epidermidis clinical isolates in a tertiary care hospital in France. J Antimicrob Chemother. 2018 Jan 1;73(1):41-51. Go to original source... Go to PubMed...
  11. Götz F, Perconti S, Popella P, Werner R, Schlag M. Epidermin and gallidermin: Staphylococcal lantibiotics. Int J Med Microbiol. 2014 Jan;304(1):63-71. Go to original source... Go to PubMed...
  12. Ruzauskas M, Siugzdiniene R, Klimiene I, Virgailis M, Mockeliunas R, Vaskeviciute L, et al. Prevalence of methicillin-resistant Staphylococcus haemolyticus in companion animals: a cross-sectional study. Ann Clin Microbiol Antimicrob. 2014 Nov 28;13:56. doi: 10.1186/s12941-014-0056-y. Go to original source... Go to PubMed...
  13. Dziri R, Klibi N, Lozano C, Ben Said L, Bellaaj R, Tenorio C, et al. High prevalence of Staphylococcus haemolyticus and Staphylococcus saprophyticus in environmental samples of a Tunisian hospital. Diagn Microbiol Infect Dis. 2016 Jun;85(2):136-40. Go to original source... Go to PubMed...
  14. Correa-Martinez CL, Tönnies H, Froböse NJ, Mellmann A, Kampmeier S. Transmission of vancomycin-resistant enterococci in the hospital setting: uncovering the patient-environment interplay. Microorganisms. 2020 Jan 31;8(2):203. doi: 10.3390/microorganisms8020203. Go to original source... Go to PubMed...
  15. El Ouali Lalami A, Touijer H, El-Akhal F, Ettayebi M, Benchemsi N, Maniar S, et. al. Microbiological monitoring of environment surfaces in a hospital in Fez city, Morocco. J Mater Environ Sci. 2016;7(1):123-30.
  16. Khan HA, Ahmad A, Mehboob R. Nosocomial infections and their control strategies. Asian Pac J Trop Biomed. 2015;5(7):509-14. Go to original source...
  17. Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of enterococci. Microbiol Spectr. 2019 Jul;7(4):10.1128/microbiolspec.GPP3-0053-2018. doi: 10.1128/microbiolspec.GPP3-0053-2018. Go to original source... Go to PubMed...
  18. Davis E, Hicks L, Ali I, Salzman E, Wang J, Snitkin E, et al. Epidemiology of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis colonization in nursing facilities. Open Forum Infect Dis. 2020 Jan 6;7(1):ofz553. doi: 10.1093/ofid/ofz553. Go to original source... Go to PubMed...
  19. Al Sa'ady AT, et. al. Detection of vancomycin resistance in multidrug-resistant Enterococcus faecalis isolated from burn infections. 2019. In Drug Invent Today. 2019;11(11):2984-9.